Selecta Biosciences (SELB) PT Raised to $7 at Needham & Company
Tweet Send to a Friend
Needham & Company analyst Chad Messer raised the price target on Selecta Biosciences (NASDAQ: SELB) to $7.00 (from $6.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
